GENE ONLINE|News &
Opinion
Blog

Bispecific Antibody
FDA Approves First Targeted Therapy for EGFR Lung Cancer with Exon 20 Mutations
2021-05-24
BMS Wins Agenus’ anti-TIGIT Asset to Bolster I-O Pipeline
2021-05-21
Researchers Design Novel Bispecific Antibodies to Nab “Hard-to-Target” Cancer Drivers
2021-03-09
Interferon-γ Pathway Helps Cancer Cells Evade Immune Therapy
2021-02-28
Lilly Strikes $1.6 Billion Deal with Merus for Cancer Treating Bispecific Antibodies
2021-01-20
R&D
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
New Frontiers in Therapeutics
2020-07-25Partner
R&D
Roche, Innovent Sign Billion Dollar Deal for Bispecific Antibodies
2020-06-11
Llama Antibodies Show Promise as Probable Coronavirus Treatment
2020-05-05
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
R&D
Meru Reports Proof of Concept for Its Bispecific Antibody in NRG1 Fusion Cancers
2019-10-29
1 2
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top